about
MiR-200c and HuR in ovarian cancerMicrotubule-binding agents: a dynamic field of cancer therapeutics.Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancerβIII-Tubulin: biomarker of taxane resistance or drug target?Molecular mode of action and role of TP53 in the sensitivity to the novel epothilone sagopilone (ZK-EPO) in A549 non-small cell lung cancer cellsSpecific β-tubulin isotypes can functionally enhance or diminish epothilone B sensitivity in non-small cell lung cancer cellsUnderstanding the basis of drug resistance of the mutants of αβ-tubulin dimer via molecular dynamics simulationsMicrotubules and their role in cellular stress in cancerThymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel.HGF/c-Met axis drives cancer aggressiveness in the neo-adjuvant setting of ovarian cancerHigher sensitivity to patupilone versus paclitaxel chemotherapy in primary uterine serous papillary carcinoma cell lines with high versus low HER-2/neu expression in vitro.Herpes virus microRNA expression and significance in serous ovarian cancerEndometrial carcinoma: a review of chemotherapy, drug resistance, and the search for new agentsDifferential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcoma cell lines is linked to tubulin-beta-III expressionNek6 and Hif-1α cooperate with the cytoskeletal gateway of drug resistance to drive outcome in serous ovarian cancer.Altered TUBB3 expression contributes to the epothilone response of mitotic cells.Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones.Improved i.p. drug delivery with bioadhesive nanoparticles.Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin.Proteomics of cancer cell lines resistant to microtubule-stabilizing agents.Class III b-tubulin overexpression in gynecologic tumors: implications for the choice of microtubule targeted agents?High-level βIII-tubulin overexpression occurs in most head and neck cancers but is unrelated to clinical outcome.Random mutagenesis of β-tubulin defines a set of dispersed mutations that confer paclitaxel resistance.An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance
P2860
Q21261258-A898E460-7564-4D10-B766-405EA8F7C1D5Q27690249-1CE98E60-DB30-48E2-ABCC-C6D4B49D992DQ28236320-4D9D43E3-1391-4E52-B7C6-26E890B2FD0FQ28284878-DB368363-102E-4AF6-85DD-F84CD2B577DDQ28477992-7EC3D022-FADE-4364-AE1C-7B05FA75644DQ28478885-A30426E0-4045-49BD-B4A0-7A5A8D40609AQ28482107-ADF5B01C-6071-4BCB-BBF3-B03D9C130A75Q33770927-1C1B321E-FB14-4370-B220-8514E2966BAAQ33903541-A4F5675C-75C9-4693-A96F-57507D80A9E6Q34104074-99A74D14-0664-4202-9903-AFB4FE265E5EQ34126568-79954F0B-7EA0-452F-8540-03BA80583FA3Q34654294-45B59ED0-D632-46F8-9F6A-81A9012F4420Q35583750-1460CF33-4DBA-470B-99E0-8811A18C83FFQ35830854-4E42C865-239A-4787-8960-40943D1DF8B8Q35929796-3A6756BE-5D14-4C49-9425-0B603BFF54FFQ36557893-94E5644F-DF2B-4EE3-B5E3-24077048E725Q36980135-E86E8C1A-06E7-4760-9CE4-366507952F70Q37346875-F638BF01-81CD-4829-B394-8EACD406B06FQ37570220-AE0DC0DF-F367-4B00-9107-824BCCB2036EQ37625745-B538A8F1-0DC8-42BF-9400-C76A96DC13CBQ38069185-478FE498-DB01-4114-830A-F46E9294F007Q38667965-C70A6306-97E4-4B71-8497-3F048BD4A4FDQ39336478-D5F5C0A1-4BF4-4CB4-867E-37A2D62AD5BBQ39414846-25CB7F98-45CA-4D63-A686-6042EFA4E529
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Molecular mechanisms of patupilone resistance
@ast
Molecular mechanisms of patupilone resistance
@en
Molecular mechanisms of patupilone resistance
@nl
type
label
Molecular mechanisms of patupilone resistance
@ast
Molecular mechanisms of patupilone resistance
@en
Molecular mechanisms of patupilone resistance
@nl
prefLabel
Molecular mechanisms of patupilone resistance
@ast
Molecular mechanisms of patupilone resistance
@en
Molecular mechanisms of patupilone resistance
@nl
P2093
P50
P1433
P1476
Molecular mechanisms of patupilone resistance
@en
P2093
Alessia Camperchioli
Cristiano Ferlini
Daniela Gallo
Raffaella Iantomasi
P304
P356
10.1158/0008-5472.CAN-08-2091
P407
P577
2008-12-15T00:00:00Z